B cells play an important role in lipopolysaccharide-induced bone resorption

Calcified Tissue International

Volumn 78, Issue 3, 2006, Pages 125-132

  Kozuka, Y ^a   Ozaki, Y ^a   Ukai, T ^a   Kaneko, T ^a   Hara, Y ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

B cell; Bone resorption; Lipopolysaccharide; Osteoclastogenesis; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALVEOLAR BONE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL ISOLATION; CONTROLLED STUDY; GINGIVA; HISTOPATHOLOGY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE ACTIVATION; TISSUE SECTION;

ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; BONE RESORPTION; CELLS, CULTURED; FEMUR; FLOW CYTOMETRY; GINGIVA; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED STRAINS; MICE, SCID; SPLEEN; TIBIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645283892     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-005-0149-x     Document Type: Article

References (34)

1. Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11:905-913
2. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ (1998) TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997-1001
3. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliot R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
4. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 95:3597-3602
5. Simonet WS, Lacy DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
6. Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142
7. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337
8. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12
9. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF (2002) Bacteria induce osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 70:3143-3148
10. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T (2000) T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-gamma. Nature 408:600-605
11. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL (1997) Lipopolysaccharide- stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100:1557-1565
12. Hara Y, Ukai T, Yoshimura A, Shiku H, Kato I (1998) Histopathological study of the role of CD4- and CD8-positive T cells on bone resorption induced by Escherichia coli endotoxin. Calcif Tissue Int 63:63-66
13. Ukai T, Hara Y, Kato I (1996) Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J Periodontal Res 31:414-422
14. Moriyama H, Ukai T, Hara Y (2002) Interferon-gamma production changes in parallel with bacterial lipoplysaccharide induced bone resorption in mice: an immunohistometrical study. Calcif Tissue Int 71:53-58
15. Medzhitov R (2001) Toll-like receptors and innate immunity. Nature Rev Immunol 1:135-145
16. Donahue AC, Fruman DA (2003) Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol 170:5851-5860
17. 2 induces expression of receptor activator of nuclear factor-kappaB ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J Bone Miner Res 15:1321-1329
18. Manabe N, Kawaguchi H, Chikuda H, Miyaura C, Inada M, Nagai R, Nabeshima Y, Nakamura K, Sinclair AM, Scheuermann RH, Kuro-o M (2001) Connection between B lymphocyte and osteoclast differentiation pathways. J Immunol 167:2625-2631
19. Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-562
20. + cells: its role in accelerated osteoclastogenesis due to estrogen deficiency. J Bone Miner Res 16:2215-2221
21. Weitzmann MN, Cenci S, Haug J, Brown C, DiPersio J, Pacifici R (2000) B lymphocytes inhibit human osteoclastogenesis by secretion of TGFβ. J Cell Biochem 78:318-324
22. Choi Y, Kim JJ (2003) B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. Exp Mol Med 35:385-392
23. Rossi JF, Chappard D, Marcelli C, Laplante J, Commes T, Baldet P, Janbon C, Jourdan J, Alexandre C, Bataille (1990) Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol 76:469-475
24. Masuzawa T, Miyaura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T (1994) Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 94:1090-1097
25. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y (1986) The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125:431-435
26. Katayama I, Li CY, Yam LT (1972) Histochemical study of acid phosphatase isoenzyme in leukemic reticuloendotheliosis. Cancer 29:157-164
27. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488
28. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286
29. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A (2000) Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858-4864
30. Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL (2004) Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol 173:4838-4846
31. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM (2000) Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106:R59-R67
32. + T cells. Eur J Immunol 31:2179-2188
33. Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL (2000) Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275:27307-27310
34. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL (1999) Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 154:203-210